TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/22/21 17:21 | 6/21/21 | VERV | Verve Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | P.d | 7,030 | 19.00 | 0 | 370 | 83 | 813 | M | |||||||||||||||
11/6/20 18:46 | 10/30/20 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | P | 2,342 | 25.44 | 0 | 92 | 70 | 224 | I | |||||||||||||||
11/6/20 18:46 | 10/30/20 | NVUS | Novus Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | S | -346 | 26.65 | 0 | -13 | -5 | 224 | I | |||||||||||||||
9/23/20 19:09 | 9/21/20 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Logos Global Management LP | CA | T | P.d | 13,300 | 19.00 | 0 | 700 | 87 | 1,504 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |